Global Stem Cell Therapy Market Analysis Report 2024-2030, by Therapy Type, Therapeutic Application (Oncology, Cardiovascular Disease, Musculoskeletal Disorders), Region and Segment Foreca...
bluebird bio, Inc. (BLUE)
Last bluebird bio, inc. earnings: 2/18 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investor.bluebirdbio.com/investor-overview
Company Research
Source: Yahoo! Finance
Application (Oncology, Cardiovascular Disease, Musculoskeletal Disorders), Region, and Segment Forecasts, 2024-2030" report has been added to ResearchAndMarkets.com's offering. The global stem cell therapy market size is anticipated to reach USD 1.67 billion by 2030 and is projected to grow at a CAGR of 24.15% from 2024 to 2030. The market growth is propelled by several key factors that underscore both scientific advancements and evolving healthcare needs.Advancements in stem cell research and technology have revolutionized the landscape of regenerative medicine. Breakthroughs in stem cell isolation, characterization, and manipulation techniques have empowered researchers to harness the therapeutic potential of stem cells with greater precision and efficacy. For instance, in May 2023, EPROCELL introduced Contract Development and Manufacturing Organization (CDMO) services for producing Advanced Therapies Medicinal Products (ATMPs) derived from mesenchymal stem cells (MSC). This expan
Show less
Read more
Impact Snapshot
Event Time:
BLUE
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
BLUE alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
BLUE alerts
High impacting bluebird bio, Inc. news events
Weekly update
A roundup of the hottest topics
BLUE
News
- 2Flo Ventures Announces Addition of Renowned Life Sciences Executive Charlotte Jones-Burton, MD, MS as a PartnerPR Newswire
- bluebird bio Appoints O. James Sterling as Chief Financial OfficerBusiness Wire
- bluebird bio, Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky for More Information - BLUEAccesswire
- bluebird bio, Inc. investors: Please contact the Portnoy Law Firm to recover your losses; May 28, 2024 deadlineGlobeNewswire
- Shareholders of bluebird bio, Inc. Should Contact Levi & Korsinsky Before May 28, 2024 to Discuss Your Rights – BLUEAccesswire
BLUE
Earnings
- 11/7/23 - Beat
BLUE
Sec Filings
- 6/13/24 - Form 3
- 6/4/24 - Form 4
- 5/29/24 - Form 8-K
- BLUE's page on the SEC website